SARS-CoV-2-IN-13

• Catalog Number: orb1689114
• Category: Small Molecules
• Description: SARS-CoV-2-IN-13
• CAS Number: 56961-10-5
• Purity: 98.15%
• MW: 327.12
• SMILES: O=C(C1=CC(Cl)=CC=C1O)NC2=CC=C([N+]([O-])=O)C(Cl)=C2
• Formula: C₁₃H₈Cl₂N₂O₄
• Biological Activity: SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when administered orally. SARS-CoV-2-IN-13 is a potent SARS-CoV-2 inhibitor with an IC 50 of 0.057 μM [1].
• Note: For research use only
• Expiration Date: 12 months from date of receipt.